| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000026980 |
| Receipt No. | R000028563 |
| Official scientific title of the study | Drug hypersensitivity study using a diagnosis algorithm to examinations of a suspected adverse drug reaction |
| Date of disclosure of the study information | 2017/04/13 |
| Last modified on | 2018/08/12 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Drug hypersensitivity study using a diagnosis algorithm to examinations of a suspected adverse drug reaction | |
| Title of the study (Brief title) | Drug hypersensitivity study using a diagnosis algorithm to examinations | |
| Region |
|
|
| Condition | ||
| Condition | In this study, we investigate drug hypersensitivity using a definitive diagnosis algorithm (modified Mirakian R. Clin Exp Allergy. 2009 Jan;39:43-61.) to examinations of a suspected adverse drug reaction. | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Determination of drugs causing adverse drug reactions |
| Basic objectives2 | Bio-equivalence |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Our definitive diagnosis algorithm has 4 steps. Primary endpoints are 1) skin prick test is positive in Step 2, 2) provocation test is positive in Step 3, and 3) significant associations between HLA types and kind of drug that has positive reaction by provocation test in Step 2.
|
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Blood test, skin prick test and provocation test. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Individuals with diagnosed and suspected drug hypersensitivity in Ehime University Hospital. | |||
| Key exclusion criteria | * Objectives without written informed concern.
* Objectives judged as ineligible by the chief of the study. * Objectives with and suspected fetal and severe systemic drug reactions. * Objectives without healthy skin region to be performed skin tests. * Objectives without the skin region untreated by steroid ointments to be performed skin tests. * Objectives with intravenous steroid within 1 month. * Objectives with intravenous immunosuppressive agent within 1 month. * Objectives with oral antiallergic drug within 1 week. * Objectives with oral antihistamine within 1 week. |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Miwa Shinohara |
| Organization | Ehime University Hospital |
| Division name | Department of Pediatrics |
| Address | 454 Shitsukawa, Toon-City Ehime, 791-0295, JAPAN |
| TEL | 089-960-5320 |
| shinohara.miwa.vv@ehime-u.ac.jp | |
| Public contact | |
| Name of contact person | Miwa Shinohara |
| Organization | Ehime University Hospital |
| Division name | Department of Pediatrics |
| Address | 454 Shitsukawa, Toon-City Ehime, 791-0295, JAPAN |
| TEL | 089-960-5320 |
| Homepage URL | |
| shinohara.miwa.vv@ehime-u.ac.jp | |
| Sponsor | |
| Institute | Department of Pediatrics, Ehime University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Pediatrics, Ehime University Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | Department of Pediatrics, Ehime University Hospital |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 愛媛大学医学部附属病院 (愛媛県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028563 |